{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:29:10Z","timestamp":1788510550496,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T00:00:00Z","timestamp":1275004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s15010-010-0022-3","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T09:04:31Z","timestamp":1274951071000},"page":"261-267","source":"Crossref","is-referenced-by-count":12,"title":["Treatment of visceral leishmaniasis in children in the Central-West Region of Brazil"],"prefix":"10.1007","volume":"38","author":[{"given":"Y. M.","family":"Brustoloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. V.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Z.","family":"C\u00f4nsolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L. L.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E. C.","family":"Dorval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. T.","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,28]]},"reference":[{"key":"22_CR1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/157489108786242341","volume":"3","author":"HC Maltezou","year":"2008","unstructured":"Maltezou HC. Visceral leishmaniasis: advances in treatment. Recent Pat Antiinfect Drug Discov. 2008;3:192\u20138.","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"22_CR2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/092986709787458489","volume":"16","author":"L Kedzierski","year":"2009","unstructured":"Kedzierski L, Sakthianandeswaren A, Curtis JM, Andrews PC, Junk PC, Kedzierska K. Leishmaniasis: current treatment and prospects for new drugs and vaccines. Curr Med Chem. 2009;16:599\u2013614.","journal-title":"Curr Med Chem"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/136485908X252142","volume":"102","author":"Y Mueller","year":"2008","unstructured":"Mueller Y, Nguimfack A, Cavailler P, Couffignal S, Rwakimari JB, Loutan L, et al. Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda. Ann Trop Med Parasitol. 2008;102:11\u20139.","journal-title":"Ann Trop Med Parasitol"},{"key":"22_CR4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00001432-200310000-00005","volume":"16","author":"J Berman","year":"2003","unstructured":"Berman J. Current treatment approaches to leishmaniasis. Curr Opin Infect Dis. 2003;16:397\u2013401.","journal-title":"Curr Opin Infect Dis"},{"key":"22_CR5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","volume":"43","author":"C Bern","year":"2006","unstructured":"Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, et al. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis. 2006;43:917\u201324.","journal-title":"Clin Infect Dis"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.arcped.2005.01.009","volume":"12","author":"P Minodier","year":"2005","unstructured":"Minodier P, Robert S, No\u00ebl G, Blanc P, Retornaz K, Garnier JM. Amphot\u00e9ricine B liposomale en premi\u00e8re intention dans la leishmaniose visc\u00e9rale infantile en r\u00e9gion Provence-Alpes-C\u00f4te-d\u2019Azur-Corse (First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France). Arch Pediatr. 2005;12:1102\u20138.","journal-title":"Arch Pediatr"},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"HW Murray","year":"2005","unstructured":"Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366:1561\u201377.","journal-title":"Lancet"},{"key":"22_CR8","first-page":"2","volume":"12","author":"E Palumbo","year":"2008","unstructured":"Palumbo E. Oral miltefosine treatment in children with visceral leishmaniasis: a brief review. Braz J Infect Dis. 2008;12:2\u20134.","journal-title":"Braz J Infect Dis"},{"key":"22_CR9","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. Coordena\u00e7\u00e3o Geral de Vigil\u00e2ncia Epidemiol\u00f3gica. Leishmaniose Visceral Grave. Normas e Condutas. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade, 2006."},{"key":"22_CR10","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. Manual de vigil\u00e2ncia e controle da leishmaniose visceral. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade, 2003."},{"key":"22_CR11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","volume":"34","author":"JD Chulay","year":"1985","unstructured":"Chulay JD, Spencer HC, Mugambi M. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Am J Trop Med Hyg. 1985;34:702\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"22_CR12","doi-asserted-by":"crossref","unstructured":"Oliveira-Neto MP, Mattos M, Pirmez C, Fernandes O, Gon\u00e7alves-Costa SC, Souza CF, et al. Mucosal leishmaniasis (espundia) responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo. 2000;42:321\u20135.","DOI":"10.1590\/S0036-46652000000600004"},{"key":"22_CR13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.medmal.2004.07.032","volume":"35","author":"A Masmoudi","year":"2005","unstructured":"Masmoudi A, Maalej N, Mseddi M, Souissi A, Turki H, Boudaya S, et al. Glucantime par voie parent\u00e9rale: b\u00e9n\u00e9fice versus toxicit\u00e9. M\u00e9d Mmal Infect. 2005;35:42\u20135.","journal-title":"M\u00e9d Mmal Infect"},{"key":"22_CR14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1258\/td.2008.080369","volume":"39","author":"ALL Oliveira","year":"2009","unstructured":"Oliveira ALL, Brustoloni YM, Fernandes TD, Dorval ME, da Cunha RV, B\u00f3ia MN. Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil. Trop Doct. 2009;39:180\u20132.","journal-title":"Trop Doct"},{"key":"22_CR15","first-page":"342","volume":"60","author":"C Rapp","year":"2000","unstructured":"Rapp C, Simon F, Dordain ML. L\u2019antimoniate de N-m\u00e9thyl glucamine, ou Glucantime. Med Trop (Mars). 2000;60:342\u20133.","journal-title":"Med Trop (Mars)"},{"key":"22_CR16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00006454-200104000-00021","volume":"20","author":"N Kuyucu","year":"2001","unstructured":"Kuyucu N, Kara C, Bakirta\u00e7 A, Tezi\u00e7 T. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate. Ped Infect Dis J. 2001;20:455\u20137.","journal-title":"Ped Infect Dis J"},{"key":"22_CR17","doi-asserted-by":"crossref","unstructured":"Ribeiro AL, Drummond JB, Volpini AC, Andrade AC, Passos VM. Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine. Braz J Med Biol Res. 1999;32:297\u2013301.","DOI":"10.1590\/S0100-879X1999000300008"},{"key":"22_CR18","first-page":"90","volume":"27","author":"EA Khalil","year":"2006","unstructured":"Khalil EA, Ahmed AE, Musa AM, Hussein MH. Antimony-induced cerebellar ataxia. Saudi Med J. 2006;27:90\u20132.","journal-title":"Saudi Med J"},{"key":"22_CR19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1590\/S0037-86822002000600014","volume":"35","author":"MA Santos","year":"2002","unstructured":"Santos MA, Marques RC, Farias CA, Vasconcelos DM, Stewart JM, Costa DL, et al. Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis. Rev Soc Bras Med Trop. 2002;35:629\u201333.","journal-title":"Rev Soc Bras Med Trop"},{"key":"22_CR20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","volume":"6","author":"S Sundar","year":"2001","unstructured":"Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health. 2001;6:849\u201354.","journal-title":"Trop Med Int Health"},{"key":"22_CR21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/317455","volume":"31","author":"HC Maltezou","year":"2000","unstructured":"Maltezou HC, Siafas C, Mavrikou M, Spyridis P, Stavrinadis C, Karpathios T, et al. Visceral leishmaniasis during childhood in southern Greece. Clin Infect Dis. 2000;31:1139\u201343.","journal-title":"Clin Infect Dis"},{"key":"22_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/02724936.1994.11747685","volume":"14","author":"B Benjamin","year":"1994","unstructured":"Benjamin B, Annobil SH, Bassuni WA. Diagnostic and management problems in childhood visceral leishmaniasis in south-western Saudi Arabia. Ann Trop Paediatr. 1994;14:7\u201313.","journal-title":"Ann Trop Paediatr"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s15010-003-3139-9","volume":"31","author":"GL Werneck","year":"2003","unstructured":"Werneck GL, Batista MS, Gomes JR, Costa DL, Costa CH. Prognostic factors for death from visceral leishmaniasis in Teresina, Brazil. Infection. 2003;31:174\u20137.","journal-title":"Infection"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-010-0022-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-010-0022-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-010-0022-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T03:25:59Z","timestamp":1591327559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-010-0022-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,28]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s15010-010-0022-3","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,28]]}}}